RSS-Feed abonnieren
DOI: 10.1055/a-1323-4036
Synthesis of a Potent Pan-Serotype Dengue Virus Inhibitor Having a Tetrahydrothienopyridine Core
We thank the Wellcome Trust Innovator Award (218216/Z/19/Z) for £500,000 in support of this research.
![](https://www.thieme-connect.de/media/synlett/202205/lookinside/thumbnails/st-2020-b0566-c_10-1055_a-1323-4036-1.jpg)
Abstract
A synthesis of the first-in-class pan-serotype dengue virus inhibitor NITD-688 is presented. The Gewald reaction of N-(tert-butoxycarbonyl)-6,6-dimethylpiperidin-3-one with malononitrile and sulfur in the presence of l-proline as a catalyst gave tert-butyl 2-amino-3-cyano-6,6-dimethyl-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxylate. This was coupled with [4-(aminosulfonyl)phenyl]acetic acid by using propanephosphonic acid anhydride. A subsequent reductive alkylation with cyclohexanecarboxaldehyde gave NITD-688. Preliminary results of our attempts to control the regioselectivity of the Gewald synthesis of the 2-amino-3-cyanothiophene core are also presented.
Key words
medicinal chemistry - Gewald reaction - tetrahydrothienopyridines - regioselectivity - dengue virus inhibitorsSupporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/a-1323-4036.
- Supporting Information
Publikationsverlauf
Eingereicht: 26. Oktober 2020
Angenommen nach Revision: 26. November 2020
Accepted Manuscript online:
26. November 2020
Artikel online veröffentlicht:
21. Dezember 2020
© 2020. Thieme. All rights reserved
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References and Notes
-
1 Current address: Novartis (Singapore) Pte Ltd, 20 Pasir Panjang Road #10-25/28 Mapletree Business City, Singapore 117439.
-
2a
Wilder-Smith A,
Ooi E.-E,
Horstick O,
Wills B.
Lancet 2019; 393: 350
- 2b Dengue and Severe Dengue. World Health Organization; Geneva: 2020. https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue (accessed Dec 15, 2020)
-
3
Halstead SB.
Hum. Vaccines Immunother. 2018; 14: 2158
- 4 World Health Organization: Vaccine . 2017: 1200
-
5
Lim SP,
Wang Q.-Y,
Noble CG,
Chen Y.-L,
Dong H,
Zou B,
Yokokawa F,
Nilar S,
Smith P,
Beer D,
Lescar J,
Shi P.-Y.
Antiviral Res. 2013; 100: 500
-
6
Lim SP.
Antiviral Res. 2019; 163: 156
-
7
Yokokawa F.
RSC Med. Chem. 2020; 11: 541
-
8
Moquin SA,
Simon O,
Karuna R,
Lakshminarayana SB,
Yokokawa F,
Wang F,
Saravanan C,
Zhang J,
Day CW,
Chan K,
Wang Q.-Y,
Lu S,
Dong H,
Wan KF,
Lim SP,
Liu W,
Seh CC,
Chen Y.-L,
Xu H,
Barkan DT,
Kounde CS,
Sim WL. S,
Wang G,
Yeo H.-Q,
Zou B,
Chan WL,
Ding M,
Song J.-G,
Li M,
Osborne C,
Blasco F,
Sarko C,
Beer D,
Bonamy GM. C,
Sasseville VG,
Shi P.-Y,
Diagana TT,
Yeung BK. S,
Gu F.
Sci. Transl. Med. 2020; DOI: DOI: 10.1126/scitranslmed.abb2181.
-
9
Wang T,
Huang X.-G,
Liu J,
Li B,
Wu J.-J,
Chen K.-X,
Zhu W.-L,
Xu X.-Y,
Zeng B.-B.
Synlett 2010; 1351
-
10
Waghmare AA,
Hindupur RM,
Pati HN.
Rev. J. Chem. 2014; 4: 53
-
11
Kounde C,
Sim WL. S,
Simon O,
Wang G,
Yeo HQ,
Yeung BK. S,
Yokokawa F,
Zou B.
WO2019244047, 2019
-
12
Jeandon C,
Constien R,
Sinnwell V,
Margaretha P.
Helv. Chim. Acta 1998; 81: 303
-
13
Sato S,
Sakamoto T,
Miyazawa E,
Kikugawa Y.
Tetrahedron 2004; 60: 7899
-
14a
Buchstaller H.-P,
Siebert CD,
Lyssy RH,
Frank I,
Duran A,
Gottschlich R,
Noe CR.
Monatsh. Chem. 2001; 132: 279
-
14b
Hawksley D,
Griffin DA,
Leeper FJ.
J. Chem. Soc., Perkin Trans. 1 2001; 144
-
14c
Madding GD,
Thompson MD.
J. Heterocycl. Chem. 1987; 24: 581
-
15 Hydride sources such as l-Selectride, lithium aluminum hydride, diisobutylaluminum hydride, or tetramethylammonium borohydride gave 1,2-reduction exclusively.
-
16
Ojima I,
Nihonyanagi M,
Kogure T,
Kumagai M,
Horiuchi S,
Nakatsugawa K,
Nagai Y.
J. Organomet. Chem. 1975; 94: 449
-
17
N-Bromosuccinimide was found to be deleterious to the reaction yield.
-
18
tert-Butyl 2-Amino-3-cyano-6,6-dimethyl-6,7-dihydrothieno- [3,2-c]pyridine-5(4H)-carboxylate (12)
l-Proline (12.66 g, 110 mmol, 1.0 equiv) and sulfur (5.27 g, 165 mmol, 1.5 equiv) were added sequentially to a solution of 11 (25 g, 110 mmol) in DMF (100 mL) at rt, and the mixture was stirred at rt for 10–15 min. Malononitrile (8 g, 121 mmol, 1.1 equiv) was added, and mixture was stirred at 55–60 °C for 10–12 h. When the reaction was complete, the mixture was washed with hexane (3 × 50 mL). The bottom DMF layer was slowly added to cold H2O (250 mL), and the precipitated solids were collected by filtration, washed with H2O (50 mL), and dried. The wet product was purified by column chromatography (silica gel, CH2Cl2–MeOH) to give 12 as a pale brown color solid; yield: 8 g (26 mmol, 24%) (96.1% pure; 96.22:0.75 isomeric mixture based on HPLC).
1H NMR (400 MHz, DMSO-d
6): δ = 17.13 (br s, 2 H), 4.18 (s, 2 H), 3.31 (s, 2 H), 2.54 (s, 2 H), 1.40 (s, 9 H), 1.38 (s, 6 H). 13C NMR (100 MHz, DMSO-d
6): δ = 1163.71, 154.76, 128.71, 115.51, 114.31, 80.68, 79.24, 55.22, 42.66, 37.85, 28.06, 27.40. HRMS (ESI): m/z [M – H]– calcd for C15H20N3O2S: 306.1271; found: 306.1281.
-
19
2-Amino-5-benzyl-6,6-dimethyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-3-carbonitrile (19): Regiocontrolled Synthesis
Pyridinium tribromide (382 mg, 1.194 mmol, 1.2 equiv) was added to a 0.1 M solution of silyl enol ether 17 (330 mg, 0.995 mmol, 1.0 equiv) in CH2Cl2 (10 mL) at 23 °C, and the mixture was stirred for 15 min. The reaction was then quenched with sat. aq Na2S2O3 and extracted with CH2Cl2 (×3). The combined organic layers were washed with brine, dried (Na2SO4), and concentrated in vacuo to provide bromide 18, which was used immediately in the next step without further purification.
Anhyd DMF (3.32 mL, 0.1 M) was added to the crude bromide 18 (1.0 equiv), NaSH (27.9 mg, 0.498 mmol, 1.5 equiv), malononitrile (24.1 mg, 0.365 mmol, 1.1 equiv), and l-proline (38.2 mg, 0.332 mmol, 1.0 equiv) under an inert atmosphere at 23 °C, and the mixture was stirred at 23 °C for 2 h. When the reaction was complete it was quenched with sat. aq Na2S2O3 and sat. aq NaHCO3, and the mixture was extracted with EtOAc (×3). The combined organic layers were washed sequentially with H2O and brine, dried (Na2SO4), and concentrated in vacuo. The residual crude mixture was redissolved in CH2Cl2 at 23 °C, silica gel (3 g) was added, and the mixture was stirred for 4 h. The solvent was then removed in vacuo and the crude residue was purified by flash column chromatography on an ISCO machine [silica gel, heptane–EtOAc (0–50%)] to give the cyano derivative 19 as a yellow solid; yield: 21 mg (20%, 0.071).
1H NMR (500 MHz, CDCl3): δ = 17.36–7.28 (m, 4 H), 7.30–7.22 (m, 1 H), 4.59 (s, 2 H), 3.66 (s, 2 H), 3.39 (t, J = 2.0 Hz, 2 H), 2.51 (d, J = 2.2 Hz, 2 H), 1.23 (s, 6 H). 13C NMR (126 MHz, CDCl3): δ = 160.56, 139.92, 129.78, 128.52 (2 C), 128.36 (2 C), 126.91, 118.51, 100.45, 86.83, 53.94, 53.05, 46.93, 37.46, 24.21 (2 C). HRMS (ESI): m/z [M + H]+ calcd for C17H20N3S: 298.1372; found: 298.1374.